Search results
‘Liquid gold’ could bring new hope to multiple sclerosis patients, study suggests: ‘Profound...
Fox News· 5 days agoResearchers may have hit "gold" when it comes to the treatment of multiple sclerosis. An...
Immunic publishes extended data from Phase 2 MS trial in peer-reviewed journal
Proactive Investors· 5 days agoImmunic is developing its small molecule investigational drug vidofludimus calcium as an oral...
'Autoantibody Signature' Flags MS Years Before Symptoms
Medscape· 4 days agoA unique autoantibody signature of multiple sclerosis (MS) is detectable in the blood of people with...
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
Proactive Investors· 5 days agoImmunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt joined Proactive's Stephen Gunnion with news of the...
TG Therapeutics Inc (TGTX) Surpasses Revenue Estimates in Q1 2024, Despite Widening Net Loss
GuruFocus.com via Yahoo Finance· 4 days agoOn the development front, efforts are underway to enhance BRIUMVI's dosing convenience and to expand...
Earnings call: TG Therapeutics sees strong Q1 growth with Briumvi
Investing.com· 2 days agoTG Therapeutics (NASDAQ: TGTX ) has reported a robust first quarter in 2024, with Briumvi, its...
Contineum Therapeutics shares coverage initiated with $25 PT by Morgan Stanley By Investing.com
Investing.com· 5 days agoThe firm highlighted the biotechnology company's focus on developing treatments for neuroscience,...